Summary
Diabetic nephropathy is the main cause of increased mortality and morbidity in IDDM patients. The effect of antihypertensive treatment on the progression of the nephropathy is highly variable. The aim of this study was to evaluate putative predictors of the progression in diabetic nephropathy during long-term antihypertensive treatment. Eighteen hypertensive IDDM patients with diabetic nephropathy, who had not been treated previously, were followed during 3 years of treatment with captopril and frusemide or bendrofluazide. Glomerular filtration rate, arterial blood pressure, albuminuria and adjusted albuminuria were used as putative predictors of rate of decline in glomerular filtration. Fall rate in glomerular filtration rate was 4.6 (4.0) mlmhr-1 year-1 (mean (SD)) during treatment. Relative change in albuminuria (ratio of first year of treatment/baseline) and albuminuria during first year of treatment were significantly correlated to fall rate in glomerular filtration rate during 3 years of treatment (r = 0.73, p > 0.001) and (r = 0.60, p > 0.01), respectively. Arterial blood pressure and glomerular filtration rate measured at baseline, during first year of treatment or relative changes in these variables did not correlate with fall rate in glomerular filtration rate during 3 years of treatment. Haemoglobin Alc, serum-cholesterol, protein intake and sodium excretion remained unchanged during treatment, and were not correlated with loss of kidney function. Reduction in albuminuria during captopril treatment predicts an attenuated rate of decline in glomerular filtration rate in early diabetic nephropathy (glomerular filtration rate <70 ml· mirr-1 · 1.73 nr-2). The finding suggests a clinical application in monitoring the efficacy of antihypertensive treatment in early diabetic nephropathy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
References
Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501
Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in type 1 diabetes. Am J Med 78: 785–794
Deckert T, Poulsen JE, Larsen M(1978) Prognosis of diabetics with diabetes onset before the age of thirtyone. I. Survival, causes of death and complications. Diabetologia 14: 363–370
Mogensen CE (1976) Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 36: 383–388
Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T (1991) Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies. Diabetologia 34: 164–170
Klahr S (1989) The modification of diet in renal disease study. N Engl J Med 320: 864–866
Steffes MW, Brown DM, Mauer SM (1979) The development, enhancement, and reversal of the secondary complications of diabetes mellitus. Hum Pathol 10: 293–299
Brenner BM (1983) Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 647–655
Hostetter TH, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380
Steffes MW, Brown DM, Mauer SM (1978) Diabetic glo-merulopathy following unilateral nephrectomy in the rat. Diabetes 27: 35–41
Parving H-H, Andersen AR, Smidt UM, Svendsen PAa (1983) Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1: 1175–1179
Mogensen CE (1982) Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ 285: 685–688
Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PAa (1987) Effect of antihypertensive treatment on kidney function in diabetic nephropathy. BMJ 294: 1443–1447
Parving H-H, Hommel E (1989) Prognosis in diabetic ne- phropathy. BMJ 299: 230–233
Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T (1989) Improved survival in patients with diabetic nephrop-athy. Diabetologia 32: 884–886
Parving H-H, Hommel E, Smidt UM (1988) Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. BMJ 297: 1086–1091
Bjorck S, Mulec H, Johnsen SAa, Norden G, Aurell M (1992) Renal protective effect of enalapril in diabetic nephropathy. BMJ 304: 339–343
Rossing P, Hommel E, Smidt UM, Parving H-H (1992) Reduction in albuminuria predicts a beneficial effect on progression in diabetic nephropathy during antihypertensive treatment. Diabetologia 35 [Suppl 1]: A147(Abstract)
Brochner-Mortensen J (1972) A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30: 271–274
Brochner-Mortensen J, Rödbro P (1976) Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 36: 35–45
Miles DW, Mogensen CE, Gundersen HJG (1970) Radioim-munoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 26: 5–11
Maroni BJ, Steinman TI, Mitch WE (1985) A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27: 58–65
Isaksson B (1980) Urinary nitrogen output as a validity test in dietary surveys. Am J Clin Nutr 33: 4–5
Apperloo AJ, de Zeeuw D, de Jong PE (1992) The initial antiproteinuric effect of antihypertensive treatment predicts the effect of the treatment on long-term renal function outcome. J Am Soc Nephrol 3: 279(Abstract)
Anderson S, Rennke HG, Garcia DL, Brenner BM (1989) Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 36: 526–536
Walker JD, Bending JJ, Dodds RA et al. (1989) Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet II: 1411–1415
Anderson S, Rennke HG, Brenner BM (1986) Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77: 1993–2000
Viberti GC, Mackintosh D, Keen H (1983) Determinants of the penetration of proteins through the glomerular barrier in insulin-dependent diabetes mellitus. Diabetes 32: 92–95
Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M (1988) Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 33: 100–106
Tomlanovich S, Deen WM, Jones HW III, Schwartz HC, Myers BD (1987) Functional nature of glomerular injury in progressive diabetic glomerulopathy. Diabetes 36: 556–565
Scandling JD, Black VM, Deen WM, Myers BD (1992) Glomerular permselectivity in healthy and nephrotic humans. Adv Nephrol 21: 159–176
Morelli E, Loon N, Meyer T, Peters W, Myers BD (1990) Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 39: 76–82
Reddi AS, Ramamurthi R, Miller M, Dhuper S, Lasker N (1991) Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats. Biochem MedMetab Biol 45: 119–131
Remuzzi G, Bertani T (1990) Is glomerulosclerosis a consequence of altered glomerular permeability to macromole-cules? Kidney Int 38: 384–394
Rossing P, Hommel E, Smidt UM, Parving H-H (1993) Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in insulin-dependent diabetic patients. Diabetes 42: 715–719
Moorhead JF, El-Nahas M, Chan MK, Varghese Z (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet II: 1309–1311
Winocour PH, Durrington PN, Ishola M, Anderson DC, Cohen H (1987) Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. BMJ 294: 1648–1651
Kasiske BL, O’Donnell MP, Schmitz PG, Kim Y, Keane WF (1990) Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int 37: 880–891
Kasiske BL, O’Donnell MP, Cleary MP, Keane WF (1988) Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33: 667–672
Kaysen GA, Davies RW (1990) Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome. J Am Soc Nephrol 1: S75-S79
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rossing, P., Hommel, E., Smidt, U.M. et al. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia 37, 511–516 (1994). https://doi.org/10.1007/s001250050140
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s001250050140